Ulcerative colitis Archives

IBD, Crohn's disease, ulcerative colitis

News & Features

Thanksgiving Turkey Could Ease Ulcerative Colitis Symptoms

Chris Anderson -

November 22, 2023

Molecular Dx

Measurable Markers in Blood Can Be Detected Up to Eight Years Before IBD Diagnosis

Chris Anderson -

November 7, 2023

News & Features

Sanofi and Teva Ink Deal Worth Potentially $1.5B for Anti-TL1A IBD Candidate

Malorye Branca -

October 5, 2023

Molecular Dx

AGA Releases Guidelines on Use of Fecal and Blood Tests for Monitoring Ulcerative Colitis

Chris Anderson -

February 21, 2023

News & Features

Prometheus’ $500M Public Offering to Fund Phase III UC, Crohn’s Studies

Chris Anderson -

December 9, 2022

Young male in stream of digital information

News & Features

Twinning is Winning

Chris Anderson -

October 14, 2022

News & Features

10 New Genetic Variants of Crohn’s Disease Susceptibility Uncovered

Chris Anderson -

August 29, 2022

Johnson & Johnson’s Janssen Research & Development will use BiomX's XMarker platform to discover microbiome-based biomarkers for inflammatory bowel disease (IBD)

News & Features

New IBD, Colorectal Tumor Treatment Target Found

Chris Anderson -

August 3, 2022

News & Features

Inflammatory Bowel Disease Study Highlights Use of Precision Medicine Tool

John Sterling -

April 28, 2022

Anatomical model of human colon with signs of chronic bowel infection

News & Features

Pfizer Acquires Arena for $6.7B To Improve Immuno-Inflammatory Offering

Alex Philippidis -

December 14, 2021

12 Page 1 of 2

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer…

Biological Robots Show Healing Potential

ACC and AHA Issue New Guideline for Preventing and Optimally Managing…

Slow Brain Waves: A Natural Shield against Epileptic Activity

Nasal Swab Test Separates High- from Low-Risk Lung Cancer Polyps

Ulcerative colitis

Thanksgiving Turkey Could Ease Ulcerative Colitis Symptoms

Measurable Markers in Blood Can Be Detected Up to Eight Years Before IBD Diagnosis

Sanofi and Teva Ink Deal Worth Potentially $1.5B for Anti-TL1A IBD Candidate

AGA Releases Guidelines on Use of Fecal and Blood Tests for Monitoring Ulcerative Colitis

Prometheus’ $500M Public Offering to Fund Phase III UC, Crohn’s Studies

Twinning is Winning

10 New Genetic Variants of Crohn’s Disease Susceptibility Uncovered

New IBD, Colorectal Tumor Treatment Target Found

Inflammatory Bowel Disease Study Highlights Use of Precision Medicine Tool

Pfizer Acquires Arena for $6.7B To Improve Immuno-Inflammatory Offering

Related Content

Nutrient Found in Red Meat and Dairy Products Could Boost Cancer Therapies

Low-Dose Radiation Therapy Unveiled as Potential Treatment for Heart Failure

Scientists Unveil Technique for Pinpointing Autoimmune Disease Causes and Treatments

Protein Allows Production of Norepinephrine Neurons from Stem Cells, with Implications for Alzheimer’s and Parkinson’s Research